
    
      Purpose of the Phase-I clinical study Evaluation of the safety,acceptability and
      immunogenicity of QazCovid-in®-COVID-19 inactivated vaccine when administeredtwice in healthy
      volunteers aged 18-50 years.

      Purpose of the Phase-II clinical study Evaluation of the safety and immunogenicity of
      QazCovid-in® - COVID-19 inactivated vaccine with single and dual use in healthy volunteers
      aged 18 and above.
    
  